GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (FRA:2Q5) » Definitions » Price-to-Funds-From-Operations

Renovaro (FRA:2Q5) Price-to-Funds-From-Operations : (As of Mar. 30, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Renovaro Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Renovaro Business Description

Industry
Traded in Other Exchanges
Address
2080 Century Park East, Suite 906, Los Angeles, CA, USA, 90067
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.